Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ED Drug Could Support Vivus
Yahoo/Zacks.com
Thursday, December 9, 2010 - 12:22pm
tags:
erectile dysfunction, Vivus, Pfizer, GSK, Avanafil
Investors Revolt Against Charles River
Minyanville
Thursday, December 9, 2010 - 12:15pm
tags:
Charles River Laboratories, investors
A Tale of Two Pharmas: Outlooks for Lilly and Merck
Seeking Alpha
Thursday, December 9, 2010 - 12:10pm
tags:
Eli Lilly, Merck
Good News for Alkermes' Pipeline
Yahoo/Zacks.com
Thursday, December 9, 2010 - 12:09pm
tags:
Alkermes, JNJ
Pfizer, Novartis, AstraZeneca Cancer Drugs Increase Heart Risks
Bloomberg
Thursday, December 9, 2010 - 12:08pm
tags:
Pfizer, Novartis, AstraZeneca, Aromasin, Femara, Arimidex
Orexigen Approval Shows That Diversification Strategy Can Work
Seeking Alpha
Thursday, December 9, 2010 - 10:55am
tags:
Orexigen, FDA, Contrave
Drug indexes flat; Teva climbs on drug study
Marketwatch
Thursday, December 9, 2010 - 10:35am
tags:
Teva Pharmaceuticals, drug stocks
The Sorry List Of Johnson & Johnson Troubles
Pharmalot
Thursday, December 9, 2010 - 10:30am
tags:
JNJ, recalls
Pfizer Names Simmons Head of Emerging Markets as Drugmaker Seeks Growth
Bloomberg
Thursday, December 9, 2010 - 10:28am
tags:
Pfizer, emerging markets
Winners and Losers at the Hematology Society Meeting
Motley Fool
Wednesday, December 8, 2010 - 6:54pm
tags:
ONYX Pharmaceuticals, Seattle Genetics, Pfizer, Celgene, Immunogen, Novartis, Bristol-Myers Squibb, Takeda, JNJ
Pfizer board comes under fire
FT.com
Wednesday, December 8, 2010 - 6:51pm
tags:
Pfizer, Jeff Kindler, Ian Read
Momenta prices stock offering
Bizjournals.com
Wednesday, December 8, 2010 - 6:51pm
tags:
stock offering, Momenta
Bayer to keep R&D expenses at 3.1 bln eur in 2011
Reuters
Wednesday, December 8, 2010 - 2:17pm
tags:
Bayer, R&D
Aastrom on the Rise Despite Misinformation on Phase 3 Data
Seeking Alpha
Wednesday, December 8, 2010 - 2:16pm
tags:
Aastrom
Biotech's Brighter Corners
TheStreet.com
Wednesday, December 8, 2010 - 2:15pm
tags:
Neurocrine, Ariad Pharmaceuticals, Oncolytics
Pharmaceuticals Pregnant and Overdue
Seeking Alpha
Wednesday, December 8, 2010 - 2:14pm
tags:
Abbott Laboratories, Amgen, Bristol-Myers Squibb, JNJ, Merck, Mylan, Pfizer
Cephalon Buys Mesoblast Stake, Drug Rights in Potential $2 Billion Deal
Bloomberg
Wednesday, December 8, 2010 - 12:45pm
tags:
Cephalon, Mesoblast, stem cells
Should You Sell Allergan Right Now?
Motley Fool
Wednesday, December 8, 2010 - 12:44pm
tags:
Allergan
Diet Drug Rally: Orexigen, Vivus, Arena
TheStreet.com
Wednesday, December 8, 2010 - 12:27pm
tags:
obesity, Orexigen, Vivus, Arena Pharmaceuticals, Contrave, Qnexa
Can New Leadership Rejuvenate Big Pharma?
Investopedia
Wednesday, December 8, 2010 - 12:25pm
tags:
AstraZeneca, GSK, Eli Lilly, Merck, Novartis, Pfizer, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.